Analyst Research

Report Title Price
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bayer AG To Acquire Herbal Medicine Maker Steigerwald Arzneimittelwerk GmbH-Reuters


Thursday, 16 May 2013 07:41am EDT 

Reuters reported that Bayer AG said it agreed to buy privately held Steigerwald Arzneimittelwerk GmbH (Steigerwald), a maker of herbal treatments. The Company added that Steigerwald generated sales of EUR 61.3 million (USD 78.8 million) in 2012 with 180 staff. It did not disclose financial terms of the takeover. 

Company Quote

101.7
0.55 +0.54%
6:30am EDT